Katharina Bürger
0000-0002-4091-2755
Publication & Citation Trends
Publications
0 total
Additive value of early-phase β-Amyloid-PET for the differential diagnosis of non-Alzheimer's disease dementia.
Cited by 0
Semantic Scholar
Alpha‐synuclein quantitative seed amplification assay predicts conversion to dementia
Cited by 0
Semantic Scholar
“The DESCRIBE-ALS-FTD study: a prospective multicenter observational study of the ALS-FTD spectrum”
Cited by 3
Semantic Scholar
Comment by European Alzheimer’s Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer’ s disease
Cited by 0
Semantic Scholar
The Economic Burden of Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Dementia: Excess Costs and Associated Clinical and Risk Factors
Cited by 0
Semantic Scholar
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS OA
Cited by 154
Semantic Scholar
Clinical Manifestations. OA
Cited by 0
Semantic Scholar
Combining cerebrospinal fluid and PI‐2620 tau‐PET for biomarker‐based stratification of Alzheimer's disease and 4R‐tauopathies OA
Cited by 14
Semantic Scholar
Research Topics
Dementia and Cognitive Impairment Research
(53)
Alzheimer's disease research and treatments
(47)
Functional Brain Connectivity Studies
(25)
Advanced Neuroimaging Techniques and Applications
(14)
Parkinson's Disease Mechanisms and Treatments
(7)
Affiliations
University of Vienna
Oregon Research Institute
Inserm
University of Freiburg
George Washington University